1
|
Ferrari A, Stark D, Peccatori FA, Fern L, Laurence V, Gaspar N, Bozovic-Spasojevic I, Smith O, De Munter J, Derwich K, Hjorth L, van der Graaf WTA, Soanes L, Jezdic S, Blondeel A, Bielack S, Douillard JY, Mountzios G, Saloustros E. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE). ESMO Open 2021; 6:100096. [PMID: 33926710 PMCID: PMC8103533 DOI: 10.1016/j.esmoop.2021.100096] [Citation(s) in RCA: 93] [Impact Index Per Article: 31.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 02/23/2021] [Accepted: 02/24/2021] [Indexed: 12/17/2022] Open
Abstract
It is well recognised that adolescents and young adults (AYA) with cancer have inequitable access to oncology services that provide expert cancer care and consider their unique needs. Subsequently, survival gains in this patient population have improved only modestly compared with older adults and children with cancer. In 2015, the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) established the joint Cancer in AYA Working Group in order to increase awareness among adult and paediatric oncology communities, enhance knowledge on specific issues in AYA and ultimately improve the standard of care for AYA with cancer across Europe. This manuscript reflects the position of this working group regarding current AYA cancer care, the challenges to be addressed and possible solutions. Key challenges include the lack of specific biological understanding of AYA cancers, the lack of access to specialised centres with age-appropriate multidisciplinary care and the lack of available clinical trials with novel therapeutics. Key recommendations include diversifying interprofessional cooperation in AYA care and specific measures to improve trial accrual, including centralising care where that is the best means to achieve trial accrual. This defines a common vision that can lead to improved outcomes for AYA with cancer in Europe.
Collapse
Affiliation(s)
- A Ferrari
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
| | - D Stark
- Leeds Institute of Medical Research, School of Medicine University of Leeds, Leeds, UK.
| | - F A Peccatori
- Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy
| | - L Fern
- Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK
| | - V Laurence
- Medical Oncology Department and SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, Paris, France
| | - N Gaspar
- Department of Oncology for Child and Adolescent, Gustave Roussy Cancer Campus, Villejuif, France
| | - I Bozovic-Spasojevic
- Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Belgrade, Republic of Serbia
| | - O Smith
- National Children's Cancer Service, Children's Health Ireland at Crumlin and Systems Biology Ireland, University College Dublin, Dublin, Ireland
| | - J De Munter
- University Hospital Ghent Cancer Center, UZ Gent, Ghent, Belgium
| | - K Derwich
- Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland
| | - L Hjorth
- Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden
| | - W T A van der Graaf
- Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - L Soanes
- Teenage Cancer Trust, London, UK
| | - S Jezdic
- Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland
| | - A Blondeel
- Department of Scientific Programme Coordination, European Society for Paediatric Oncology (SIOPE), Brussels, Belgium
| | - S Bielack
- Zentrum für Kinder, Jugend und Frauenmedizin Pädiatrie 5, KlinikumStuttgart - Olgahospital, Stuttgart, Germany
| | - J-Y Douillard
- Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland
| | - G Mountzios
- 2nd Department of Medical Oncology and Clinical Trial Unit, Henry Dunant Hospital, Athens, Greece
| | - E Saloustros
- Department of Oncology, University Hospital of Larissa, Larissa, Greece
| |
Collapse
|
2
|
Sędek Ł, Bulsa J, Sonsala A, Twardoch M, Wieczorek M, Malinowska I, Derwich K, Niedźwiecki M, Sobol-Milejska G, Kowalczyk JR, Mazur B, Szczepański T. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: How different are they from their normal counterparts? Cytometry 2014; 86:329-39. [DOI: 10.1002/cyto.b.21176] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2013] [Revised: 04/24/2014] [Accepted: 04/24/2014] [Indexed: 01/14/2023]
Affiliation(s)
- Ł. Sędek
- Department of Pediatric Hematology and Oncology; Medical University of Silesia; Zabrze Poland
| | - J. Bulsa
- Department of Pediatric Hematology and Oncology; Medical University of Silesia; Zabrze Poland
| | - A. Sonsala
- Department of Pediatric Hematology and Oncology; Medical University of Silesia; Zabrze Poland
| | - M. Twardoch
- Department of Pediatric Hematology and Oncology; Medical University of Silesia; Zabrze Poland
| | - M. Wieczorek
- Division of Hematology; Chorzów Center of Pediatrics and Oncology; Chorzów Poland
| | - I. Malinowska
- Department of Pediatric Hematology and Oncology; Medical University of Warsaw; Poland
| | - K. Derwich
- Department of Pediatric Hematology; Oncology and Transplantology, University of Medical Sciences; Poznań Poland
| | - M. Niedźwiecki
- Department of Pediatric Hematology; Oncology and Endocrinology, Medical University; Gdansk Poland
| | - G. Sobol-Milejska
- Department of Pediatrics; Medical University of Silesia; Katowice Poland
| | - J. R. Kowalczyk
- Department of Pediatric Hematology and Oncology; Medical University; Lublin Poland
| | - B. Mazur
- Department of Microbiology and Immunology; Medical University of Silesia; Zabrze Poland
| | - T. Szczepański
- Department of Pediatric Hematology and Oncology; Medical University of Silesia; Zabrze Poland
| |
Collapse
|
3
|
Sędek L, Bulsa J, Sonsala A, Twardoch M, Wieczorek M, Malinowska I, Derwich K, Niedźwiecki M, Sobol-Milejska G, Kowalczyk JR, Mazur B, Szczepański T. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: How different are they from their normal counterparts? Cytometry B Clin Cytom 2014:n/a-n/a. [PMID: 24777855 DOI: 10.1002/cytob.21176] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2013] [Revised: 04/18/2014] [Accepted: 04/24/2014] [Indexed: 11/07/2022]
Affiliation(s)
- L Sędek
- Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Derwich K, Wachowiak J, Zając-Spychała O, Balcerska A, Balwierz W, Chybicka A, Kowalczyk JR, Matysiak M, Jackowska T, Sońta-Jakimczyk D, Szczepański T, Wysocki M. Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group. memo 2011. [DOI: 10.1007/s12254-011-0279-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Skoczen S, Klus K, Armata J, Kowalczyk J, Wisniewska-Slusarz H, Kolecki P, Derwich K, Matysiak M, Krauze A, Rokicka-Milewska R, Pawelec K, Boguslawska-Jaworska J, Juszczak K, Pisarek J, Sońta-Jakimczyk D, Tomaszewska R, Łuszczynska A, Wysocki M, Styczyński J. [High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group]. Med Wieku Rozwoj 2003; 4:23-32. [PMID: 12021459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
The paper presents the experience of the Polish Paediatric Leukaemia/Lymphoma Study Group in the treatment of high-risk acute lymphoblastic leukaemia in children using a new version of the New York (1997-1999). Protocol with treatment intensity adjusted according to the age of the patients. From April 1997 to December 1999 a group of 49 children with leukocytosis ranging from 50 900/mm3 to 580 000/mm3 (median 122 000/mm3) and 6 children with leukocytosis below 50 000/mm3 and poor response to steroids were treated with this protocol. Children below 10 years (43 patients) were treated according to the previous protocol, children above 10 years (12 patients) were treated with intensified protocol (high doses of ARA-C in consolidation and intermediate doses of Mtx in maintenance). Induction was identical for all patients. Complete remission was achieved in 92.6% patients. There were 2 relapses. Six children died - 3 without remission, 2 due to a relapse, 1 due to treatment complications. The current opinions concerning classification of HRG-ALL and treatment possibilities in this group of children are discussed.
Collapse
Affiliation(s)
- S Skoczen
- Klinika Onkologii i Hematologii Dzieciecej, Polsko-Amerykanski Instytut Pediatrii, Collegium Medicum, Uniwersytetu Jagielońskiego, 30-663 Kraków, ul. Wielicka 265, Poland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Sońta-Jakimczyk D, Olejnik I, Armata J, Bogusławska-Jaworska J, Kołecki P, Kowalczyk J, Rokicka-Milewska R, Chybicka A, Derwich K, Drabko K, Hicke-Roberts A, Kubiczek K, Steczowicz M. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma]. Wiad Lek 2000; 51 Suppl 4:52-8. [PMID: 10731944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
We present courses and treatment's results in 8 infants with acute lymphoblastic leukaemia (ALL) treated according Dana-Faber Cancer Institute protocol between 1994-1998 year. Complete remission (RC) was achieved in 8 children. Relapses were diagnosed between 6 to 20 month, only one achieved II RC. Four children are alive: in I RC-2, in II RC-1, in partial remission 1 and the treatment was ended in one. Treatment's results in infants with ALL are still unsatisfactory.
Collapse
Affiliation(s)
- D Sońta-Jakimczyk
- Katedry i Kliniki Hematologii Dzieciecej i Chemioterapii Slaskiej Akademii Medycznej w Katowicach
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Stefańska K, Derwich K, Kaczmarek-Kanold M. 47P Dawka MTX, jego eliminacja a objawy toksyczne. Rep Pract Oncol Radiother 1998. [DOI: 10.1016/s1507-1367(98)70253-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
9
|
Stencel D, Derwich K, Kaczmarek-Kanold M. Transitory diabetes mellitus in children during treatment of acute lymphoblastic leukemia. Rep Pract Oncol Radiother 1998. [DOI: 10.1016/s1507-1367(98)70173-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
10
|
Derwich K, Stancel D, Warzywoda M, Leda M. 45P Uszkodzenie trzustki w przebiegu terapii L-Asparaginazą u dzieci z ostrą białaczką limfoblastyczną. Rep Pract Oncol Radiother 1998. [DOI: 10.1016/s1507-1367(98)70251-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
11
|
Stencel D, Derwich K, Kaczmarek-Kanold M. 43P Cukrzyca insulinozależna w przebiegu terapii ostrej białaczki limfoblastycznej u dzieci. Rep Pract Oncol Radiother 1998. [DOI: 10.1016/s1507-1367(98)70249-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|